Arkolith/Insider Trading/DNLI/Form 4

Ho Carole

Chief Medical OfficerDenali Therapeutics Inc. (DNLI) · full profile →Form 4 · filed Aug 22, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$550K
Net Open-Market Flow
-$550K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 21, 2024Sell(S)14K$24.41$344K125K
Aug 21, 2024Sell(S)6K$24.96$147K119K
Aug 20, 2024Sell(S)2K$23.79$58K139K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001714899-24-000194) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML